RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2001; 86(01): 413-419
DOI: 10.1055/s-0037-1616239
DOI: 10.1055/s-0037-1616239
Research Article
Annexins: Key Regulators of Haemostasis, Thrombosis, and Apoptosis
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
12. Dezember 2017 (online)
Summary
Annexins form a family of proteins on the basis of structural and functional criteria. Their physiological relevance is still not fully understood, but is thought to involve phospholipid membrane associated processes. Recent data shed clues about their function in the regulation of thrombosis, haemostasis and apoptosis. These data arise from a multitude of physicochemical, cell biological, animal and clinical studies. This review presents this data and discusses them in the light of the novel understanding that apoptotic cells can contribute to thrombotic and haemostatic processes.
-
References
- 1 Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1994; 1197: 63-93.
- 2 Gerke V, Moss SE. Annexins and membrane dynamics. Biochim Biophys Acta 1997; 1357: 129-54.
- 3 Seaton BA, Dedman JR. Annexins. Biometals 1998; 11: 399-404.
- 4 Geisow MJ, Fritsche U, Hexham JM, Dash B, Johnson T. A consensus amino-acid sequence repeat in Torpedo and mammalian Ca2+-dependent membrane-binding proteins. Nature 1986; 320: 636-8.
- 5 Geisow MJ, Walker JH, Boustead C, Taylor W. Annexins-new family of Ca2+-regulated-phospholipid binding protein. Biosci Rep 1987; 7: 289-98.
- 6 Crumpton MJ, Dedman JR. A protein terminology tangle. Nature 1990; 345: 212.
- 7 Morgan RO, Jenkins NA, Gilbert DJ, Copeland NG, Balsara BR, Testa JR, Fernandez MP. Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution. Genomics 1999; 60: 40-9.
- 8 Huber R, Romisch J, Paques EP. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J 1990; 9: 3867-74.
- 9 Huber R, Schneider M, Mayr I, Romisch J, Paques EP. The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution. Implications for membrane binding and calcium channel activity. FEBS Lett 1990; 275: 15-21.
- 10 Sopkova J, Renouard M, Lewit BA. The crystal structure of a new high-calcium form of annexin V. J Mol Biol 1993; 234: 816-25.
- 11 Swairjo MA, Concha NO, Kaetzel MA, Dedman JR, Seaton BA. Ca2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nat Struct Biol 1995; 2: 968-74.
- 12 Tait JF, Sakata M, McMullen BA, Miao CH, Funakoshi T, Hendrickson LE, Fujikawa K. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family. Biochemistry 1988; 27: 6268-76.
- 13 Blackwood RA, Ernst JD. Characterization of Ca2+-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J 1990; 266: 195-200.
- 14 Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990; 265: 4923-8.
- 15 Meers P, Daleke D, Hong K, Papahadjopoulos D. Interactions of annexins with membrane phospholipids. Biochemistry 1991; 30: 2903-8.
- 16 Lecat S, Verkade P, Thiele C, Fiedler K, Simons K, Lafont F. Different properties of two isoforms of annexin XIII in MDCK cells. J Cell Science 2000; 113: 2607-18.
- 17 Babiychuk EB, Draeger A. Annexins in cell membrane dynamics: Ca2+-regulated association of lipid microdomains. J Cell Biol 2000; 150: 1113-23.
- 18 Meers P, Mealy T. Phospholipid determinants for annexin V binding sites and the role of tryptophan 187. Biochemistry 1994; 33: 5829-37.
- 19 Reviakine I, Bergsma Schutter W, Mazeres Dubut C, Govorukhina N, Brisson A. Surface topography of the p3 and p6 annexin V crystal forms determined by atomic force microscopy. J Struct Biol 2000; 131: 234-9.
- 20 Oling F, Santos J, Govorukhina N, Mazeres Dubut C, Bergsma Schutter W, Oostergetel G, Keegstra W, Lambert O, Lewit Bentley A, Brisson A. Structure of membrane-bound annexin A5 trimers: A hybrid Cryo-EM – X-ray crystallography study. J Mol Biol 2000; 304: 561-73.
- 21 Mosser G, Ravanat C, Freyssinet JM, Brisson A. Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol 1991; 217: 241-5.
- 22 Zanotti G, Malpeli G, Gliubich F, Folli C, Stoppini M, Olivi L, Savoia A, Berni R. Structure of the trigonal crystal form of bovine annexin IV. Biochem J 1998; 329 Part 1: 101-6.
- 23 Newman R, Tucker A, Ferguson C, Tsernoglou D, Leonard K, Crumpton MJ. Crystallization of p68 on lipid monolayers and as three-dimensional single crystals. J Mol Biol 1989; 206: 213-9.
- 24 Langen R, Isas JM, Luecke H, Haigler HT, Hubbell WL. Membrane-mediated assembly of annexins studied by site-directed spin labeling. J Biol Chem 1998; 273: 22453-7.
- 25 Kaetzel MA, Dedman JR. Annexins: Novel Ca2+-dependent regulators of membrane function. N Physiol Sci 1995; 10: 171-6.
- 26 Creutz CE. The annexins and exocytosis. Science 1992; 258: 924-31.
- 27 Grewal T, Heeren J, Mewawala D, Schnitgerhans T, Wendt D, Salomon G, Enrich C, Beisiegel U, Jackle S. Annexin VI stimulates endocytosis and is involved in the trafficking of low density lipoprotein to the prelysosomal compartment. J Biol Chem 2000; 275: 33806-13.
- 28 Diakonova M, Gerke V, Ernst J, Liautard JP, van der Vusse G, Griffiths G. Localization of five annexins in J774 macrophages and on isolated phagosomes. J Cell Sci 1997; 110: 1199-213.
- 29 Oliferenko S, Paiha K, Harder T, Gerke V, Schwarzler C, Schwarz H, Beug H, Gunthert U, Huber LA. Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol 1999; 146: 843-54.
- 30 Buhl WJ, Garcia MT, Zipfel M, Schiebler W, Gehring U. A series of annexins from human placenta and their characterization by use of an endogenous phospholipase A2. Eur J Cell Biol 1991; 56: 381-90.
- 31 Mira JP, Dubois T, Oudinet JP, Lukowski S, Russo Marie F, Geny B. Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition. J Biol Chem 1997; 272: 10474-82.
- 32 Schlaepfer DD, Jones J, Haigler HT. Inhibition of protein kinase C by annexin V. Biochemistry 1992; 31: 1886-91.
- 33 Dubois T, Mira JP, Feliers D, Solito E, RussoMarie F, Oudinet JP. Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem J 1998; 330: 1277-82.
- 34 Hofmann A, Benz J, Liemann S, Huber R. Voltage dependent binding of annexin V, annexin VI and annexin VII-core to acidic phospholipid membranes. Biochim Biophys Acta 1997; 1330: 254-64.
- 35 Kourie JI, Wood HB. Biophysical and molecular properties of annexin-formed channels. Prog Biophys Mol Biol 2000; 73: 91-134.
- 36 Isas JM, Cartailler JP, Sokolov Y, Patel DR, Langen R, Luecke H, Hall JE, Haigler HT. Annexins V and XII insert into bilayers at mildly acidic pH and form ion channels. Biochemistry 2000; 39: 3015-22.
- 37 Vermes I, Steur E, Reutelingsperger C, Haanen C. Decreased concentration of Annexin V in Parkinsonian cerebrospinal fluid: Speculation on the underlying cause. Mov Disord 1999; 14: 1008-10.
- 38 Christmas P, Callaway J, Fallon J, Jones J, Haigler HT. Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland. J Biol Chem 1991; 266: 2499-507.
- 39 Hall SE, Lim S, Witherden IR, Tetley TD, Barnes PJ, Kamal AM, Smith SF. Lung type II cell and macrophage annexin I release: differential effects of two glucocorticoids. Am J Physiol 1999; 20: L114-L121.
- 40 Thorin B, Gache G, Dubois T, Grataroli R, Domingo N, Russomarie F, Lafont H. Annexin VI is secreted in human bile. Biochem Biophys Res Com 1995; 209: 1039-45.
- 41 Flaherty MJ, West S, Heimark RL, Fujikawa K, Tait JF. Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system. J Lab Clin Med 1990; 115: 174-81.
- 42 Römisch J, Schuler E, Bastian B, Burger T, Dunkel FG, Schwinn A, Hartmann AA, Paques EP. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul Fibrinolysis 1992; 3: 11-7.
- 43 Benevolensky D, Belikova Y, Mohammadzadeh R, Trouve P, Marotte F, Russo Marie F, Samuel JL, Charlemagne D. Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure. Lab Invest 2000; 80: 123-33.
- 44 Cirino G, Flower RJ, Browning JL, Sinclair LK, Pepinsky RB. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature 1987; 328: 270-2.
- 45 M DA Di Filippo C, La M, Solito E, McLean PG, Flower RJ, Oliani SM, Perretti M. Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. Faseb J 2000; 14: 1867-9.
- 46 Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen tissue plasminogen activator 1. Identity with annexin II. J Biol Chem 1994; 269: 21191-7.
- 47 Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA) .2. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994; 269: 21198-203.
- 48 Fitzpatrick SL, Kassam G, Choi KS, Kang HM, Fogg DK, Waisman DM. Regulation of plasmin activity by annexin II tetramer. Biochemistry 2000; 39: 1021-8.
- 49 Reutelingsperger CPM, Hornstra G, Hemker HC. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985; 151: 625-9.
- 50 Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989; 264: 7944-9.
- 51 Vanheerde WL, Degroot PG, Reutelingsperger CPM. The complexity of the phospholipid binding protein annexin V. Thromb Haemost 1995; 73: 172-9.
- 52 Romisch J, Seiffge D, Reiner G, Paques EP, Heimburger N. In-vivo antithrombotic potency of placenta protein 4 (annexin V). Thromb Res 1991; 61: 93-104.
- 53 Vanheerde WL, Sakariassen KS, Hemker HC, Sixma JJ, Reutelingsperger CPM, Degroot PG. Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. Arterioscler Thromb 1994; 14: 824-30.
- 54 Thiagarajan P, Benedict CR. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 1997; 96: 2339-47.
- 55 Rand JH. “Annexinopathies” – A new class of diseases. N Engl J Med 1999; 340: 1035-6.
- 56 Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 1999; 340: 994-1004.
- 57 Donohoe S, Kingdom JCP, Mackie IJ, Burrell S, Quenby S, Jauniaux E, Machin SJ. Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. Thromb Haemost 2000; 84: 32-8.
- 58 Rand JH, Wu XX, Andree HAM, Lockwood CJ, Guller S, Scher J, Harpel PC. Pregnancy loss in the antiphospholipid-antibody syndrome – A possible thrombogenic mechanism. N Engl J Med 1997; 337: 154-60.
- 59 Wang XQ, Campos B, Kaetzel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999; 180: 1008-16.
- 60 Huppertz B, Frank HG, Kingdom JCP, Reister F, Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998; 110: 495-508.
- 61 Andree HA, Stuart MC, Hermens WT, Reutelingsperger CPM, Hemker HC, Frederik PM, Willems GM. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 1992; 267: 17907-12.
- 62 Rauch J. Lupus anticoagulant antibodies: Recognition of phospholipid-binding protein complexes. Lupus 1998; 7: S29-S31.
- 63 Nakamura N, Ban T, Yamaji K, Yoneda Y, Wada Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset. J Clin Invest 1998; 101: 1951-9.
- 64 Vermes I, Haanen C, Reutelingsperger CPM. Molecular Biology of apoptosis and programmed cell death. In: O. I. Aruoma, B. Halliwell, eds. Molecular Biology of free radicals in human diseases. OICA Intern.; London UK: 1998: 225-86.
- 65 Glücksman A. Cell deaths in normal vertebrate ontogeny. Biol Rev Camb Philos Soc 1951; 26: 59-86.
- 66 Kerr JFR. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 1971; 105: 15-20.
- 67 Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
- 68 Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-9.
- 69 Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
- 70 Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000; 407: 777-83.
- 71 Krammer PH. CD95′s deadly mission in the immune system. Nature 2000; 407: 789-95.
- 72 Meier P, Finch A, Evan G. Apoptosis in development. Nature 2000; 407: 796-801.
- 73 Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000; 405: 85-90.
- 74 Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 4029-35.
- 75 Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-16.
- 76 Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32.
- 77 Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Vanoers MHJ. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-20.
- 78 Homburg CHE, Dehaas M, Vondemborne AEGK, Verhoeven AJ, Reutelingsperger CPM, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire annexin V binding sites during apoptosis in vitro. Blood 1995; 85: 532-40.
- 79 Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-56.
- 80 Vermes I, Haanen C, Steffensnakken H, Reutelingsperger C. A novel assay for apoptosis – Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.
- 81 Verhoven B, Schlegel RA, Williamson P. Mechanism of phosphatidylserine exposure, a phagocyte recognition signal on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597-601.
- 82 Freyssinet JM, Toti F, Hugel B, Gidon Jeangirard C, Kunzelmann C, Martinez MC, Meyer D. Apoptosis in vascular disease. Thromb Haemost 1999; 82: 727-35.
- 83 Ding J, Wu Z, Crider BP, Ma Y, Li X, Slaughter C, Gong L, Xie XS. Identification and functional expression of four isoforms of ATPase II the putative aminophospholipid translocase. Effect of isoform variation on the ATPase activity and phospholipid specificity. J Biol Chem 2000; 275: 23378-86.
- 84 Wiedmer T, Zhou Q, Kwoh DY, Sims PJ. Identification of three new members of the phospholipid scramblase gene family. Biochim Biophys Acta 2000; 1467: 244-53.
- 85 Marguet D, Luciani MF, Moynault A, Williamson P, Chimini G. Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey. Nat Cell Biol 1999; 1: 454-6.
- 86 Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000; 2: 399-406.
- 87 Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 1998; 5: 551-62.
- 88 Balasubramanian K, Chandra J, Schroit AJ. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J Biol Chem 1997; 272: 31113-7.
- 89 Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998; 188: 2313-20.
- 90 Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996; 93: 1624-9.
- 91 Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL, Freyssinet JM. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997; 99: 1546-54.
- 92 Flynn PD, Byrne CD, Baglin TP, Weissberg PL, Bennett MR. Thrombin generation by apoptotic vascular smooth muscle cells. Blood 1997; 89: 4378-84.
- 93 Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 2429-42.
- 94 Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75: 281-9.
- 95 Van den Eijnde SM, Boshart L, Reutelingsperger CPM, DeZeeuw CI, VermeijKeers C. Phosphatidylserine plasma membrane asymmetry in vivo: A pancellular phenomenon which alters during apoptosis. Cell Death Differ 1997; 4: 311-6.
- 96 Van den Eijnde SM, Luijsterburg AJ, Boshart L, De Zeeuw CI, van Dierendonck JH, Reutelingsperger CPM, Vermeij Keers C. In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure. Cytometry 1997; 29: 313-20.
- 97 Van den Eijnde SM, Lips J, Boshart L, Marani E, Reutelingsperger CPM, De Zeeuw CI. Spatiotemporal distribution of dying neurons during early mouse development. Eur J Neurosci 1999; 11: 712-24.
- 98 Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996; 149: 367-80.
- 99 Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703-11.
- 100 Tricot O, Mallat Z, Heymes C, Belmin J, Leseche G, Tedgui A. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 2000; 101: 2450-3.
- 101 Walsh K, Isner JM. Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall. Cardiovasc Res 2000; 45: 756-65.
- 102 Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-53.
- 103 Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998; 95: 6349-54.
- 104 Blankenberg FG, Robbins RC, Stoot JH, Vriens PW, Berry GJ, Tait JF, Strauss HW. Radionuclide imaging of acute lung transplant rejection with annexin V. Chest 2000; 117: 834-40.
- 105 Kown MH, Van der Steenhoven T, Blankenberg FG, Hoyt G, Berry GJ, Tait JF, Strauss HW, Robbins RC. Zinc-mediated reduction of apoptosis in cardiac allografts. Circulation 2000; 102: 228-32.
- 106 D’Arceuil H, Rhine W, De Crespigny A, Yenari M, Tait J, Strauss W, Engelhorn T, Kastrup A, Moseley M, Blankenburg F. 99 mTc Annexin V imaging of neonatal hypoxic brain injury. Circulation 2000; 32: 2692-700.
- 107 Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, DeMuinck E, Wellens HJJ, Kemerink GJ, Reutelingsperger CPM, Heidendal GA. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000; 356: 209-12.
- 108 Dumont E, Hofstra L, van Heerde WL, van den Eijnde S, Doevendans PAF, DeMuinck E, Daemen M, Smits JFM, Frederik P, Wellens HJJ, Daemen M, Reutelingsperger CPM. Cardiomyocyte death induced by myocardial ischemia and reperfusion – Measurement with recombinant human annexin-V in a mouse model. Circulation 2000; 102: 1564-8.
- 109 Reutelingsperger C, Hofstra L. Visualisation of cell death. Lancet 2000; 356: 2014.